
EMV Capital
Description
EMV Capital is a London-based venture capital firm deeply embedded within the NetScientific Group, serving as its investment manager for direct investments and managing its Enterprise Investment Scheme (EIS) funds. The firm focuses on early-stage, high-growth deep technology companies across critical sectors including life science, sustainability, and industrials. Their investment thesis centers on identifying businesses with robust intellectual property, substantial market potential, and seasoned management teams capable of executing on their vision.
EMV Capital typically provides initial funding ranging from £500,000 to £5 million, which translates to approximately $635,000 to $6.35 million based on recent exchange rates. Beyond capital, the firm adopts a hands-on approach, offering strategic and operational support to its portfolio companies to accelerate their development and market penetration. They actively work to syndicate deals, bringing in strategic corporate and institutional co-investors to facilitate larger funding rounds and provide additional value to their ventures.
Their affiliation with NetScientific provides a strong ecosystem for portfolio companies, often leading to follow-on funding opportunities and access to a broader network. For instance, companies within the NetScientific portfolio, which EMV Capital helps manage, collectively raised over £20 million in 2023, underscoring the group's active role in capital formation for deep tech innovation. EMV Capital's strategy is designed to not only provide initial growth capital but also to foster long-term success through active engagement and strategic partnerships, aiming to commercialize disruptive technologies with significant societal and economic impact.
Investor Profile
EMV Capital has backed more than 31 startups, with 3 new investments in the last 12 months alone. The firm has led 24 rounds, about 77% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Israel.
- Strong thematic focus on Medical, Health Care, Artificial Intelligence (AI).
- Led 2 rounds in the past year.
- Typical check size: $635K – $6.3M.
Stage Focus
- Series Unknown (39%)
- Seed (32%)
- Series A (19%)
- Convertible Note (3%)
- Debt Financing (3%)
- Private Equity (3%)
Country Focus
- United Kingdom (65%)
- United States (29%)
- Israel (6%)
Industry Focus
- Medical
- Health Care
- Artificial Intelligence (Ai)
- Software
- Computer
- Satellite Communication
- Telecommunications
- Wireless
- Machine Learning
- Oncology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.